Home
Explore services
Integrated solutions
Data & analytics
Tailored Reporting
Strategy & consulting
AI
Industry focus
Enterprise, mid-market & emerging pharmaceutical
Biotechnology
Financial Institutions
Education
Professional services
How we help
Pricing strategy & market access
Health technology assessment
Regulatory compliance
Commercial strategy & launch planning
Contact us
Responsive Menu
Home
Explore services
▼
Integrated solutions
Data & analytics
Tailored Reporting
Strategy & consulting
AI
Industry focus
▼
Enterprise, mid-market & emerging pharmaceutical
Biotechnology
Financial Institutions
Education
Professional services
How we help
▼
Pricing strategy & market access
Health technology assessment
Regulatory compliance
Commercial strategy & launch planning
Contact us
LOGIN
Canada’s PMPRB drug pricing reforms face
additional legal challenges
Yearly Archives:
2022
Canada’s PMPRB drug pricing reforms face additional legal challenges
By Margaret Labban, PhD
24 February 2022
Read More
Growing number of US states enacting legislation to lower drug prices
By Margaret Labban, PhD
15 February 2022
Read More
NICE’s latest reform – why was it needed and what does it mean for innovation?
By Sevcan Cigerli
28 January 2022
Read More
Next posts
Stay Informed
Sign up to receive the latest news and trends
straight into your inbox from GPI
LOGIN 
